製品の概要

  • 製品名Anti-SOX17 antibody [3B10]
    SOX17 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [3B10] to SOX17
  • アプリケーション適用あり: Flow Cyt, WB, ICC/IF, IHC-P, ICCmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Recombinant protein, expressed in E.coli corresponding to amino acids 177-414 of Human SOX17

  • ポジティブ・コントロール
    • Cell lysate from transfected HEK293 or HeLa cells expressing SOX17.
  • 特記事項ab84990 should be diluted with PBS before use.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab84990 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
Flow Cyt 1/1000. ab170190-Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.
WB 1/5000 - 1/10000. Predicted molecular weight: 44 kDa.
ICC/IF 1/50 - 1/100.
IHC-P 1/50.
ICC Use at an assay dependent concentration.

ターゲット情報

  • 機能Acts as transcription regulator that binds target promoter DNA and bends the DNA. Binds to the sequences 5'-AACAAT-'3 or 5'-AACAAAG-3'. Modulates transcriptional regulation via WNT3A. Inhibits Wnt signaling. Promotes degradation of activated CTNNB1. Plays a key role in the regulation of embryonic development. Required for normal looping of the embryonic heart tube. Required for normal development of the definitive gut endoderm. Probable transcriptional activator in the premeiotic germ cells.
  • 組織特異性Expressed in adult heart, lung, spleen, testis, ovary, placenta, fetal lung, and kidney. In normal gastrointestinal tract, it is preferentially expressed in esophagus, stomach and small intestine than in colon and rectum.
  • 関連疾患Defects in SOX17 are the cause of vesicoureteral reflux type 3 (VUR3) [MIM:613674]. VUR3 is a disease belonging to the group of congenital anomalies of the kidney and urinary tract. It is characterized by the reflux of urine from the bladder into the ureters and sometimes into the kidneys, and is a risk factor for urinary tract infections. Primary disease results from a developmental defect of the ureterovesical junction. In combination with intrarenal reflux, the resulting inflammatory reaction may result in renal injury or scarring, also called reflux nephropathy. Extensive renal scarring impairs renal function and may predispose patients to hypertension, proteinuria, renal insufficiency and end-stage renal disease.
  • 配列類似性Contains 1 HMG box DNA-binding domain.
    Contains 1 Sox C-terminal domain.
  • 細胞内局在Nucleus.
  • Information by UniProt
  • 参照データベース
  • 別名
    • FLJ22252 antibody
    • SOX17 antibody
    • SOX17_HUMAN antibody
    • SRY (sex determining region Y) box 17 antibody
    • SRY box 17 antibody
    • SRY related HMG box transcription factor SOX17 antibody
    • Transcription factor SOX-17 antibody
    • Transcription factor SOX17 antibody
    • VUR3 antibody
    see all

Anti-SOX17 antibody [3B10] 画像

  • Immunocytochemical immunoflurescence analysis of acetone-fixed human iCell® Neurons, labelling SOX17 with ab84990 at a dilution of1/500 incubated for 24 hours at 4°C in 10% FBS. Blocking was with 5% serum incubated for 1 hour at 25°C. Secondary was a goat anti-mouse polyclonal Alexa Fluor® 594 conjugate at 1/1000.

    See Abreview

  • Anti-SOX17 antibody [3B10] (ab84990) at 1/10000 dilution + Lysate from HEK- 293T cells transfected with Human Sox17 expression vector

    Predicted band size : 44 kDa
    Observed band size : 44 kDa
    HEK293T cell lysates were generated from transient transfection of the cDNA clone (RC200035)
  • ab84990 use in Flow cytometry.
    HEK293T cells transfected with either pCMV6-ENTRY SOX17 (Red) or empty vector control plasmid (Blue) were immunostained with ab84990 at a 1/1000 dilution.
  • ab 84990 staining of SOX17 in HeLa cells transiently transfected with a SOX17 expression vector by immunofluorescence.
  • ab84990 staining HeLa cells by immunofluorescence.

Anti-SOX17 antibody [3B10] (ab84990) 使用論文

This product has been referenced in:
  • Pennarossa G  et al. Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells. Proc Natl Acad Sci U S A 110:8948-53 (2013). Human . Read more (PubMed: 23696663) »
  • Zhang X  et al. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene : (2012). Read more (PubMed: 22777357) »

See all 2 Publications for this product

Product Wall

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Immunocytochemistry
Sample Human Cultured Cells (NPCs derived from iPSC)
Permeabilization Yes - 0.25% Triton X-100 in PBS
Specification NPCs derived from iPSC
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 1% · Temperature: 22°C
Fixative Paraformaldehyde
Username

Abcam user community

Verified customer

投稿 Feb 10 2016

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (iCell® Neurons)
Permeabilization No
Specification iCell® Neurons
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Fixative Acetone
Username

Abcam user community

Verified customer

投稿 Sep 17 2015

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"